Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "Head"

1974 News Found

Lonza posts CHF 6.5 billion in 2025 sales, marks strong profit growth
News | January 30, 2026

Lonza posts CHF 6.5 billion in 2025 sales, marks strong profit growth

Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model


Lubrizol showcases India manufacturing expansion at WHX Dubai
News | January 29, 2026

Lubrizol showcases India manufacturing expansion at WHX Dubai

The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices


Roche’s investigational obesity drug CT-388 delivers dramatic weight loss in Phase II trial
News | January 29, 2026

Roche’s investigational obesity drug CT-388 delivers dramatic weight loss in Phase II trial

The Phase III programme, Enith1 and Enith2, is expected to launch this quarter


CitiusTech & Ventra Health unveil AI-powered revenue game-changer
News | January 29, 2026

CitiusTech & Ventra Health unveil AI-powered revenue game-changer

The platform uses cutting-edge AI and automation to tackle the entire revenue cycle


Trelegy Ellipta gets green light in China for adults with uncontrolled asthma
News | January 28, 2026

Trelegy Ellipta gets green light in China for adults with uncontrolled asthma

The approval expands the drug’s existing COPD indication, making it the only single-inhaler triple therapy (SITT) available for both respiratory conditions in China


Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report
News | January 24, 2026

Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report

The research shows 93% of global companies now cover weight-management drugs in their health insurance plans


Lupin receives highest ESG rating from CDP for climate change and water security
Sustainability | January 24, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability


FDA nod to Boehringer Ingelheim's heart disease treatment for dogs 'Vetmedin'
Drug Approval | January 23, 2026

FDA nod to Boehringer Ingelheim's heart disease treatment for dogs 'Vetmedin'

VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs